rethinkPeptides Search
Menu
Study breakdown

Pufferfish Skin Peptide Could Help Lower Blood Pressure

In VitroPreliminary evidence
The takeaway

A peptide (FNLRMQ) derived from pufferfish skin collagen showed ACE-inhibiting activity and protected blood vessel cells from damage through Nrf2/HO-1 and PI3K/Akt/eNOS pathways.

Dual pathway protection

FNLRMQ activated both Nrf2/HO-1 antioxidant and PI3K/Akt/eNOS vascular protective signaling

What the researchers found

The collagen-derived peptide FNLRMQ inhibits ACE activity and protects blood vessel endothelial cells from angiotensin II-induced injury through Nrf2/HO-1 and PI3K/Akt/eNOS signaling pathways.

Why it matters

High blood pressure affects over a billion people worldwide. Natural ACE-inhibiting peptides from marine sources could provide alternatives to synthetic ACE inhibitor drugs with potentially fewer side effects.

The numbers in context

Peptide FNLRMQ; ACE inhibition confirmed; Nrf2/HO-1 and PI3K/Akt/eNOS pathways activated

How the study worked

Molecular docking to identify ACE-inhibitory peptides from pufferfish collagen hydrolysate, followed by in vitro testing on angiotensin II-induced HUVECs for cell viability, apoptosis, and signaling pathway analysis.

Who was studied

Human umbilical vein endothelial cells (HUVECs) in culture

What this study cannot tell us

In vitro study only using human cell lines. No animal or human trial data. Single peptide tested. Bioavailability and stability in the body not assessed.

How to read the evidence

In vitro study with human endothelial cells and clear mechanistic data. Preliminary evidence requiring animal model validation.

When this study was published

Published in 2021, part of growing interest in marine-derived bioactive peptides.

The bigger picture

Marine-derived bioactive peptides are an expanding area of pharmaceutical research. This study demonstrates that fish skin, often discarded as waste, can yield peptides with genuine therapeutic potential for cardiovascular health.

Questions still open

  • Would FNLRMQ lower blood pressure in animal models?
  • How does this peptide's ACE inhibition compare to established drugs like lisinopril?
  • Can the peptide survive digestion to reach the bloodstream?

Common questions

What is ACE and why does blocking it help blood pressure?
ACE (angiotensin-converting enzyme) produces angiotensin II, which constricts blood vessels and raises blood pressure. Blocking ACE reduces angiotensin II production, allowing blood vessels to relax and lowering blood pressure.
Could a fish skin peptide really become a blood pressure medication?
It's early-stage research, but marine-derived peptides that inhibit ACE are being actively studied. The challenge is ensuring these peptides survive digestion and reach the bloodstream in active form.

Read the original research

ACE Inhibitory Peptide from Skin Collagen Hydrolysate of Takifugu bimaculatus as Potential for Protecting HUVECs Injury.

Marine drugs, 19(12)

Citation

Cai, Shuilin; Pan, Nan; Xu, Min; Su, Yongchang; Qiao, Kun; Chen, Bei; Zheng, Bingde; Xiao, Meitian; Liu, Zhiyu. (2021). ACE Inhibitory Peptide from Skin Collagen Hydrolysate of Takifugu bimaculatus as Potential for Protecting HUVECs Injury.. Marine drugs, 19(12). https://doi.org/10.3390/md19120655